本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Rocket Pharmaceuticals, Inc.

6.27
-0.2900-4.42%
盘后6.25-0.0200-0.32%19:46 EDT
成交量:208.10万
成交额:1,299.86万
市值:6.76亿
市盈率:-2.40
高:6.43
开:6.35
低:6.11
收:6.56
数据加载中...
2024/04/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/05

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/03/29

重要事件披露

Form 8-K - Current report
2024/03/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/27

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/26

重要事件披露

Form 8-K - Current report
2024/02/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

重要事件披露

Form 8-K - Current report
2024/02/08

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/13

重要事件披露

Form 8-K - Current report